Proscia, a medical technology start-up that is dedicated to bringing computer intelligence to pathology, has announced the launch of its first-generation software platform. This initial product release provides multi-gigabyte digital biopsy cloud-based storage and leverages the company’s second-opinion collaboration technology.
Proscia’s cloud-based, modular software platform offers large-scale management, analysis, access, and collaboration for whole slide images in digital pathology. This debut provides an easily managed, highly scalable digital slide repository, with secure data access. Customers include hospitals, academic research institutions, commercial pathology labs, as well as pharmaceutical and biotech companies.
The Proscia platform employs several key technologies to access, analyse and share whole slide images with speed, accuracy and quality. “There are tens of millions of biopsies performed annually, analysed solely by the human eye,” stated David West Jr., Proscia founder and CEO. “This is archaic. We built a modern computing platform that aims to revolutionise the 150-year-old pathology workflow. Our software can discover and process millions of critical data points that will help pathologists and healthcare providers to diagnose, treat and ultimately prevent cancer.” Proscia’s technologies combine multi-tenant cloud computing, image analysis and machine learning with proprietary algorithms to bring unprecedented computer intelligence to the pathology field.
Key features of the Proscia platform that allow users to greatly improve whole slide image workflows include: secure storage, annotation and collaboration on multi-gigabyte digital biopsies; high resolution, deep zoom viewing; and support for all leading whole slide scan formats, as well as static images.
